Literature DB >> 22290372

The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat.

H J Cassaday1, H Hodges, J A Gray.   

Abstract

When animals are exposed to a stimulus that has no consequences they are subsequently impaired in learning that this stimulus predicts an important event, such as footshock. This retarding effect of stimulus pre-exposure is called latent inhibition (LI) and is reliably disrupted by amphetamine, antipsychotics having an opposite effect. The present experiments investigated whether agents which affect serotonergic transmission also attenuate LI, using a conditioned suppression of drinking procedure. The results showed that the 5-HT(2) antagonist ritanserin (2.0 mg/kg), and the 5-HT(1b) agonist RU 24969 (0.5 and 10.0 mg/kg) attenuated LI by increasing learning in pre-exposed animals, whilst the effects of the 5-HT(1a) agonist 8-OH-DPAT (0.38 mg/kg), though in a similar direction, were not significant. These experiments provide partial support for the involvement of serotonin in LI. Since amphetamine-induced attenuation of LI has been proposed as a model for the attentional deficits found in acute schizophrenia, these results are discussed in terms of the possible involvement of reduced serotonergic function in schizophrenic attentional disorder.

Entities:  

Year:  1993        PMID: 22290372     DOI: 10.1177/026988119300700110

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  13 in total

1.  Reduced activity at the 5-HT(2C) receptor enhances reversal learning by decreasing the influence of previously non-rewarded associations.

Authors:  S R O Nilsson; T L Ripley; E M Somerville; P G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2012-05-29       Impact factor: 4.530

2.  5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze.

Authors:  G Malleret; R Hen; J L Guillou; L Segu; M C Buhot
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

3.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites.

Authors:  R L Jakab; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

Review 4.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

5.  Differences in serotonin and dopamine metabolism in the rat brain in latent inhibition.

Authors:  G F Molodtsova
Journal:  Neurosci Behav Physiol       Date:  2003-03

6.  Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.

Authors:  L M McDonald; P M Moran; G N Vythelingum; M H Joseph; J D Stephenson; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

7.  Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

Authors:  Andrew J D Nelson; Karen E Thur; Charles A Marsden; Helen J Cassaday
Journal:  Int J Neuropsychopharmacol       Date:  2011-04-18       Impact factor: 5.176

8.  Dissociable effects of 5-HT2C receptor antagonism and genetic inactivation on perseverance and learned non-reward in an egocentric spatial reversal task.

Authors:  Simon R O Nilsson; Elizabeth M Somerville; Peter G Clifton
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

9.  Paradoxical effects of low dose MDMA on latent inhibition in the rat.

Authors:  A J D Nelson; K E Thur; C A Marsden; H J Cassaday
Journal:  Neuropharmacology       Date:  2012-11-29       Impact factor: 5.250

Review 10.  Molecular and Functional Characterization of Bacopa monniera: A Retrospective Review.

Authors:  Koilmani Emmanuvel Rajan; Jayakumar Preethi; Hemant K Singh
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.